Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Just a thought:
Marvin Baker has his office at Buck Lake.
ForeverBoard's production is/will be at Buck Lake.
SMEV will carry the investment in Buck Lake.
What will LIGA generate revenue in?
I wish LIGA would have their books audited, but will they?
Here is the website for your article:
https://fintel.io/news/sec-sues-eight-alleged-social-media-pump-dump-schemers-630
RGBP was only scheduled for 15 minutes, so Koos only lost 1 minute.
Happy Thanksgiving nilremerlin and all MJNA friends and investors.
Thanks, Past and Present. I'm looking forward to spending time with my sister's family and my son-in-law. Have a wonderful Thanksgiving to all my PKTX friends.
Medical Marijuana signs deal with leading European manufacturer and distributor
Sep. 08, 2022 9:26 AM ETMedical Marijuana, Inc. (MJNA)By: Deepa Sarvaiya, SA News Editor2 Comments
Medical Marijuana's (OTCPK:MJNA) subsidiary, Kannaway signs a distribution agreement with long-time partner Complete Hemp Technologies to expand its capabilities in the European market.
The agreement adds warehousing and daily operations to the services that CHT already provides to Kannaway in Europe, providing cost-savings and gross margins improvements in one of the company’s largest international markets.
The company has worked with CHT for years to facilitate expansion throughout Europe, leveraging their strong relationships with regulators and industry leading cannabis based product capabilities.
“As the first US company to enter Europe with our hemp-based products, we have built long-standing relationships with the region’s most knowledgeable companies and this agreement is a perfect example of that. It is a win-win for both companies. We will continue to leverage our superior product formulations and brand equity as the original trusted source for quality products, while being supported by a reputable company with a proven track record of success.” said Medical Marijuana, Inc. CEO Blake Schroeder.
https://seekingalpha.com/news/3881232-medical-marijuana-signs-deal-with-leading-european-manufacturer-and-distributor
Exactly, building hurricane resistance homes was a thing of the future for LIGA. LIGA appears to have dropped that business plan completely and has not established a new one. Good luck to everyone. I wish Marv Baker didn't separate the LIGA into two individual companies.
Schuller, thanks for the explanation of RGBP's news information. $RGBP
The way I see it, RGBP's year ends on September 30th.
FORM TYPE RECEIVED PERIOD END DATE REPORT
10-K 12/22/2021 09/30/2021
I made that mistake also; it will be out in November or 45 days after the close of quarter.
Thanks, you are correct!
I'm looking forward to October 17th to read MJNA's 3rd quarter 2022 financial reports. To read how MJNA has been doing and what we can expect in the future.
Current Report Filing (8-k)
September 20 2022 - 07:04AM
Edgar (US Regulatory)
Thanks Past and present. I'm looking forward to fall, it has been a long hot summer.
Buck Lake Ranch in Angola, IN will be hosting some summer activities according to the web site at https://bucklakeranch.com/ It will be interesting to see how that goes.
I don't understand your calculation of the AS vs OS. It is my belief that the AS and OS would reverse split at the same rate or 50>1.
Yes!
The second quarter financial report should be filed on August 15th. Maybe we will get some clue about what is going on with LIGA then. I hope the financials are audited even though they are not the finals for the year.
I hope we receive an up-to-date LIGA business plan soon. Once LIGA makes the reverse-split on October 18, 2022, the business plan will need to support a stock price of $.075 or the value of our holdings will be even less than today's price of $.0015.
I wonder if LIGA has hired an audit team yet. LIGA needs audited financials to verify the accuracy of the reports filed with the SEC. It would be the most valuable action Marv Baker could do for his faithful investors. LIGA investors, enjoy your weekend!
Sport, I am an accountant, not a scientist. I don't think a scientist would know what an accountant does, in detail, and I sure don't know what a scientist does. You will need to ask someone else.
This was nice to see:
DAILY ADVANCERS:
OTCQB Venture Market Logo
AQSZF + 312.84 %
OTCQB Venture Market Logo
AGLAF + 157.91 %
OTCQB Venture Market Logo
GENPF + 125.54 %
OTCQB Venture Market Logo
EFSH + 66.96 %
OTCQB Venture Market Logo
PKTX + 53.13 %
Great news today:
ProtoKinetix Successfully Completes Phase 1 Clinical Trials for the Treatment of Type 1 Diabetes in Islet Cell Transplants - Press Release | 07/20/2022
ProtoKinetix, Incorporated (www.protokinetix.com) (the "Company" or "ProtoKinetix") (OTCQB: PKTX), a clinical-stage biomedical company, today announced that the University of Alberta has successfully completed Phase 1 clinical trial enrollment for the treatment of type 1 diabetes in islet cell transplants. The molecule, PKX-001 (AAGP®) successfully achieved, to date, the primary safety objectives. The trial is continuing with observation of the latest enrolled patients to monitor secondary objectives over the next 6-months. Following this period of follow-up, all secondary objectives will have been evaluated in all patients, and the data will be collated, analyzed, and reported.
The trial is being led by Dr. James Shapiro, MD, PhD, FRCSC, MSM FCAHS, AHS Director of Clinical Islet, Liver Transplant and Living Donor Liver Transplant Programs, Canada Research Chair in Transplant Surgery and Regenerative Medicine, Professor of Surgery, Medicine and Surgical Oncology, University of Alberta.
“We are excited to move forward with dose escalation in this exciting trial using this anti-aging glyopeptide molecule AAGP, and eagerly await data on how this might improve and protect islets after transplant. Certainly, at this point the data shows the molecule is safe” - Dr. James Shapiro.
Dr. James Shapiro Bio
To obtain additional information and monitor updates regarding this trial please use the following link: Clinicaltrials.gov – Islet Transplantation Using PKX-001.
Original News Release found here:
https://www.otcmarkets.com/stock/PKTX/news/ProtoKinetix-Successfully-Completes-Phase-1-Clinical-Trials-for-the-Treatment-of-Type-1-Diabetes-in-Islet-Cell-Transplan?id=365432
Past and present, thank you! God bless America and our past and present service men and women that have fought to keep our homes safe and free. Stay safe.
Or there may be news Monday morning and the information was leaking.
LIGA needs to hire a qualified CPA firm to verify the general ledger entries are correct and the financial statement balances. If you review the 03/31/2022 Consolidated Balance Sheet, you will find that you must add $290,000 as an item to balance the Total Other Assets. What does the $290,000 item represent? How can an investor rely on the financials if they don't balance?
Nitro Holdings LLC @NitroHoldings · 12h
$SMEV The 90 acre Aquaculture farm has been blessed with massive amounts of crawfish this season, Small sample pics below. We've begun selling them to the public and have had very good feedback so far. Sales are starting to pick up, Many say the best crawfish in NC! Update soon
https://twitter.com/SMEVMerger/status/1538667631342927873
Aarin, there are so many questions regarding what is going on at LIGA.
I often wondered why LIGA acquired SMEV?
Didn't LIGA own more of the Live Stor America before it was spun-off?
Now LIGA will, most likely, spin-off BGTV?
Buck Lake is on LIGA's books; will it be spun-off into SMEV?
Most likely, Robert Plarr will become the CEO of LIGA. LIGA already has a 50% Joint Venture with Live Stor Ltd. Once BGTV and SMEV (Buck Lake) are spun-off, LIGA would become a holding company with LIGA as a sub-division (LIGA) and investments in Live Stor America, BGTV and SMEV.
All in my opinion!.
IMO, the most informative part of today's press release is:
Randy1111, sorry but I was asking a question, not stating a fact. I don't know what is going on with LIGA, but yes it would be illegal (in my opinion) if it is true. I wish we knew what is going on with LIGA. I also wish LIGA would move ahead with having their books audited.
Aarin, what I don't understand is:
How can assets of one company (LIGA) be used to finance a separate company (SMEV) when they are two separate legal companies with LIGA investors having no claim to SMEV's assets?
To me, either SMEV must be a Sub-division of LIGA or SMEV must set up a liability for any LIGA assets used to finance SMEV.
Aarin, what are your thoughts?
art35, you repeated the following statement twice without changing the wording at all.
Now, that is funny. We need a little humor now and then. Thanks.
I went to StockChart.com (SC) to check the other "major players in Cell Transplant Markets." to see what their stock price was. I found that four of the companies were probably followed by SC and the other four were not. The four I found on SC have a stock price of:
Regan Biopharma (RGBP) = $0.0048.
Global Cord Blood Corporation (CO) = $2.60.
Lonza Group (LZAGY) = $56.76.
Pluristem Therapeutic (PSTI) = $1.55.
Question: Why is RGBP the first on the list while the price per share in so low?
Note: I can't guarantee the second two symbols represent the companies on the list.
Thanks Kuskuk, the following is the substance of RGBP's 8-K:
Item 3.02. Unregistered Sales of Equity Securities
On May 16, 2022 Regen Biopharma, Inc. (the “Company”) issued 100,000,000 common shares (“Shares”) to Coventry Enterprises LLC in satisfaction of $334,800 of convertible indebtedness. The principal balance remaining on the $1,500,000 promissory note issued to Coventry Enterprises LLC is $648,001 as of May 16,2022.
All the abovementioned securities were issued pursuant to Section 4(a) (2) of the securities Act of 1933, as amended (the “Act”). No underwriters were retained to serve as placement agents for the sale. The securities were sold directly through our management. No commission or other consideration was paid in connection with the sale of the securities. There was no advertisement or general solicitation made in connection with this Offer and Sale of securities.
Item 8.01. Other Events
On May 10, 2022 the United States Patent and Trademark Office issued Patent No. 11,324,719 B2 to KCL Therapeutics, Inc. ( a wholly owned subsidiary of the Company) in connection with the invention titled “Small molecule agonists and antagonists of NR2F6 activity in humans”. The invention relates to compounds useful to alteration of NR2F6 activity.
LIG Assets, Inc. filed their 10-Q for 3/31/2022. The following is the Web Address:
https://www.otcmarkets.com/otcapi/company/financial-report/333313/content
The 10-Q reports Revenue LIGA = zero and BGTV = $334,937. Net Profit = $64,814. Net Profit/Revenue = 19.35%. Looking forward to the start-up of ForeverBoard production.
PhotoKinetix, Inc. filed the first quarter 2022 10-Q on 5/10/2022.
https://www.otcmarkets.com/filing/html?id=15804978&guid=uTKwkpPkNgO-Qth
LIGA filed an Attorney Letter for their Annual Report on 4/28/2022.
"Attorney Letter with Respect to Current Information - 2021 Attorney Attestation"
https://www.otcmarkets.com/otcapi/company/financial-report/329553/content
They also filed a revised Annual Report on 4/28/2022.
https://www.otcmarkets.com/otcapi/company/financial-report/329550/content
merlin, I will set it up on excel and watch it to see if it gives me extra info. Thanks.